scispace - formally typeset
A

Andrew Retter

Researcher at Guy's and St Thomas' NHS Foundation Trust

Publications -  38
Citations -  906

Andrew Retter is an academic researcher from Guy's and St Thomas' NHS Foundation Trust. The author has contributed to research in topics: Extracorporeal membrane oxygenation & Medicine. The author has an hindex of 11, co-authored 30 publications receiving 603 citations. Previous affiliations of Andrew Retter include St Thomas' Hospital.

Papers
More filters
Journal ArticleDOI

Guidelines on the management of anaemia and red cell transfusion in adult critically ill patients.

TL;DR: The use of red cells to manage anaemia during critical illness when major haemorrhage is not present and a subsequent BCSH guideline will specifically cover the use of plasma components in critically ill patients is recommended.
Journal ArticleDOI

Image-proven thromboembolism in patients with severe COVID-19 in a tertiary critical care unit in the United Kingdom.

TL;DR: Venous thrombosis is common in patients with severe COVID-19 pneumonia and many of these thromBoses may be immunothromboses due to local inflammation, rather than thromboembolic disease.
Journal ArticleDOI

Prevalence of Venous Thrombosis Following Venovenous Extracorporeal Membrane Oxygenation in Patients With Severe Respiratory Failure.

TL;DR: The prevalence of deep vein thrombosis following decannulation from extracorporeal membrane oxygenation for severe respiratory failure is clinically significant, and routine venous Doppler ultrasound followingdecannulation is warranted in this population.
Journal ArticleDOI

Severe Respiratory Failure, Extracorporeal Membrane Oxygenation, and Intracranial Hemorrhage.

TL;DR: For patients supported with veno-venous extracorporeal membrane oxygenation, the occurrence of intracranial hemorrhage is associated with a high mortality as discussed by the authors, however, it is unclear whether intracanial hemorrhages is a consequence of the extracororeal intervention or of the underlying severe respira.
Journal ArticleDOI

Survival benefit of extracorporeal membrane oxygenation in severe COVID-19: a multi-centre-matched cohort study

TL;DR: In this article , a multi-centre retrospective study was conducted in COVID-19 patients from 111 hospitals, referred to two specialist ECMO centers in the United Kingdom (UK) (March 2020 to February 2021).